CACNB2

CACNB2 encodes Cavβ2, an auxiliary β-subunit of voltage-gated calcium channels that functions as both an essential regulator of L-type calcium channel trafficking and gating, and a MAGUK-family scaffolding protein with channel-independent roles. Cavβ2 chaperones the CaV1.2 pore-forming α1C subunit to the plasma membrane and modulates channel activation voltage, inactivation kinetics, and recovery from inactivation, with loss-of-function mutations causing Brugada syndrome and short QT syndrome through reduced L-type calcium current (PMID:35955449, PMID:35894107, PMID:21357697). Beyond its channel function, Cavβ2 maintains N-cadherin–based adherens junctions in cardiomyocytes through its SH3 and guanylate kinase MAGUK domains, and its loss disrupts cardiac morphogenesis in zebrafish (PMID:22274990, PMID:18419826). CACNB2 expression is post-transcriptionally repressed by miR-499-5p, which directly targets its 3′ UTR to reduce CaV1.2 surface expression in both cardiomyocytes and hippocampal neurons, where this pathway regulates dendritogenesis and memory (PMID:28239561, PMID:35969184).

1. 2008 Medium

   Establishing that Cavβ2 subunits belong to the MAGUK protein family with conserved SH3 and guanylate kinase domains, and undergo developmentally regulated alternative splicing, provided the structural basis for understanding both channel-dependent and channel-independent functions.

   Evidence cDNA cloning, RT-PCR, and comparative genomic analysis of zebrafish Cavβ2 splice variants

   PMID:18419826

   Open questions at the time

   • Domain-deletion studies mapping which domains mediate channel-independent scaffolding were not performed
   • Functional consequences of individual splice variants were not tested electrophysiologically
2. 2011 High

   Resolving why embryonic Cavβ2 loss is lethal while adult cardiomyocytes tolerate >96% Cavβ2 depletion with only modest (~29%) L-type current reduction demonstrated that Cavβ2's role as the dominant β-subunit regulating CaV1.2 current is developmentally stage-dependent.

   Evidence Conditional cardiomyocyte-specific knockout in adult mice with patch clamp and western blot

   PMID:21357697

   Open questions at the time

   • Mechanism of residual L-type current in adult cardiomyocytes lacking Cavβ2 is unknown
   • Whether other β-subunits compensate functionally without changing protein levels was not resolved
3. 2012 Medium

   Demonstrating that Cavβ2 depletion impairs both cardiac contractility (rescued by L-type channel agonism) and N-cadherin membrane accumulation (not rescued by channel modulation) established a dual function: channel-dependent excitation-contraction coupling and channel-independent MAGUK-mediated cell adhesion.

   Evidence Morpholino knockdown in zebrafish with pharmacological epistasis and N-cadherin immunofluorescence

   PMID:22274990

   Open questions at the time

   • Morpholino off-target effects not excluded by genetic mutant
   • Direct physical interaction between Cavβ2 and N-cadherin was not demonstrated biochemically
4. 2014 High

   Showing that ASD-associated CACNB2 missense mutations differentially accelerate or decelerate channel inactivation kinetics established that Cavβ2 is a tunable modulator of CaV1.2 gating, not merely an on/off trafficking switch.

   Evidence Whole-cell patch clamp of mutant β2 subunits co-expressed with α1C in HEK-293 cells

   PMID:24752249

   Open questions at the time

   • Neuronal consequences of these mutations were not tested
   • Whether altered kinetics translate to altered calcium signaling in cardiomyocytes or neurons in vivo is unknown
5. 2017 High

   Identifying miR-499 as a direct post-transcriptional repressor of CACNB2 that secondarily reduces CACNA1C protein revealed a miRNA-mediated mechanism for coordinated downregulation of the calcium channel complex.

   Evidence Luciferase reporter assay and Argonaute pulldown in HL-1 atrial cardiomyocytes

   PMID:28239561

   Open questions at the time

   • In vivo cardiac phenotype of miR-499-mediated CACNB2 suppression was not assessed
   • Whether miR-499 regulates other β-subunit family members was not tested
6. 2022 High

   Three parallel studies established disease-causal mechanisms for CACNB2 variants: a Brugada syndrome S142F variant causes L-type current loss-of-function (rescued by CRISPR correction), an SQT5 S480L variant downregulates CACNB2 via promoter hypermethylation (rescued by demethylase overexpression), and miR-499-5p targeting of CACNB2 in hippocampal neurons impairs dendritogenesis and memory in a Cacna1c-dependent epistatic manner.

   Evidence hiPSC-CM electrophysiology with isogenic CRISPR correction, bisulfite sequencing with demethylase rescue, and in vivo hippocampal miR-499-5p injection with behavioral testing in Cacna1c haploinsufficient rats

   PMID:35894107 PMID:35955449 PMID:35969184

   Open questions at the time

   • Structural basis for how S142F and S480L mutations alter β2-α1C interaction is unknown
   • Whether promoter hypermethylation is a general mechanism for CACNB2 silencing beyond SQT5 is untested
   • Whether miR-499-5p-CACNB2 axis operates in human neurons is unconfirmed
7. 2026 Medium

   Demonstrating that CACNB2 overexpression attenuates atrial fibrosis and suppresses TGF-β/Smad signaling in an atrial fibrillation model extended Cavβ2's role beyond channel gating to anti-fibrotic signaling in atrial tissue.

   Evidence In vivo rat AF model and primary atrial fibroblast culture with CACNB2 overexpression, western blot for TGF-β/Smad pathway

   PMID:41748049

   Open questions at the time

   • Gain-of-function only; loss-of-function confirmation needed
   • Whether anti-fibrotic effect is channel-dependent or channel-independent was not resolved
   • No domain mapping for TGF-β/Smad suppression

• The structural basis of Cavβ2's dual function — how the same protein switches between channel auxiliary subunit and MAGUK scaffolding roles — remains unresolved, as does the in vivo relevance of its channel-independent RAS-MAPK signaling and anti-fibrotic activities.
• No high-resolution structure of Cavβ2 in complex with N-cadherin or other junctional partners
• Channel-independent signaling (RAS-MAPK, TGF-β/Smad) lacks loss-of-function and domain-mapping validation
• Relative contribution of individual splice variants to cardiac versus neuronal functions is unknown